Changeflow GovPing Healthcare Scientific Literature Reference Rao 2017 FDA-20...
Routine Notice Added Final

Scientific Literature Reference Rao 2017 FDA-2026-P-3869

Favicon for www.regulations.gov Regs.gov: Food and Drug Administration
Published
Detected
Email

Summary

A scientific literature reference (Rao 2017) has been submitted to FDA docket FDA-2026-P-3869. The document appears to be supporting scientific literature provided as part of comments or a submission to the FDA regulatory process. No regulatory requirements, deadlines, or penalties are established by this document submission.

What changed

A scientific literature reference authored by Rao in 2017 has been added to FDA docket FDA-2026-P-3869. The document appears to be submitted as supporting material for regulatory comments or a petition response. This type of submission provides scientific context for FDA review but does not independently establish regulatory requirements.

Affected parties submitting scientific literature to FDA dockets should ensure proper citation formatting and relevant context for FDA reviewers. Stakeholders monitoring FDA-2026-P-3869 should review this additional submission when assessing the overall docket record.

What to do next

  1. Monitor for updates to FDA-2026-P-3869 docket

Archived snapshot

Apr 15, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

Download File

Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from Regs.gov.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
Regs.gov
Published
2026-P-3869
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
FDA-2026-P-3869-0142
Docket
FDA-2026-P-3869

Who this affects

Applies to
Pharmaceutical companies Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Scientific literature submission Regulatory comment filing
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Regulatory Affairs
Compliance frameworks
GxP
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!